AstraZeneca presented data from the phase 3 BATURA study which showed that use of Airsupra in those with mild asthma reduced ...

They're produced by an industry-leading manufacturer, but one U.S. agency warns of a defect concerning this well known ...

WILMINGTON, Del. - AstraZeneca (Market cap: $219.79B), a prominent player in the pharmaceuticals industry with an "GREAT" financial health rating according to InvestingPro, announced its triple ...

Positive high-level results from the Phase III KALOS and LOGOS trials in patients with uncontrolled asthma showed that AstraZeneca ... We sell different types of products and services to both ...

These asthma data build on the well-established ... You may report side effects related to AstraZeneca products. KALOS and LOGOS Phase III trials KALOS and LOGOS are replicate confirmatory ...

It further highlights the inactive pipeline products in this ... for the treatment of Asthma. GlaxoSmithKline, Chia Tai Tianqing Pharmaceutical Group, AstraZeneca, Oneness Biotech Co., Ltd ...

The moderate to severe atopic dermatitis market is experiencing strong growth driven by rising global prevalence and heightened awareness, fueling de ...

Medscape Medical News, May 05, 2025 AstraZeneca's 'smoker's Lung' Therapy Meets Main Goals Of Late-stage Asthma Trials AstraZeneca said on Friday its triple-combination inhaler Breztri Aerosphere ...

Stryker , a global leader in medical technologies, announced that its OptaBlate basivertebral nerve ablation system (OptaBlate BVN) received 510(k) clearance from the U.S. Food and Drug Administration ...

UCB, a global biopharmaceutical company, and Domino Data Lab, provider of a leading data science platform trusted by the world's largest enterprises, today announced a strategic collaboration aimed at ...